Top Papers

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unex... 2012 2026 2016 2021 1.1k
  1. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial (2012)

Citation Paths

Find how Peter Higgins's papers are connected to another author through citations.

Rankless by CCL
2026